超越尺度:探索超肥胖症 (BMI ≥50) 中甲状腺切除术的结果
Maggie Phillips1, Ramsha Akhund1, M Chandler McLeod1
1Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
The Journal of surgical research
|May 14, 2025
概括
副甲状腺切除术对于超肥胖患者来说是安全的,成功率和并发症率相似. 然而,这些患者表现出独特的病理,需要更多的住院治疗,特别是在大量的医疗中心.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 超级肥胖 (BMI ≥50) 带来了独特的外科手术挑战.
- 超肥胖对甲状腺切除术结果的影响在很大程度上仍未被探索.
- 这项研究探讨了经过副甲状腺切除术的超肥胖患者的手术风险,康复和成功率.
研究的目的:
- 在超肥胖个体中评估副甲状腺切除术的安全性和有效性.
- 为了比较超肥胖和非超肥胖患者进行副甲状腺切除术的结果.
- 在超肥胖患者中识别独特的病理发现和恢复模式.
主要方法:
- 从2000年到2024年,对3206名患者 (84名超肥胖,3076名非超肥胖) 进行了回顾性队列分析.
- 评估的结果包括并发症率,治愈率,以及手术前/手术后的实验室值.
- 统计分析比较了超肥胖和非超肥胖群体之间的结果.
主要成果:
- 超肥胖患者年轻,手术前维生素D水平较低.
- 在超肥胖组中观察到更高的双重腺瘤和恶性瘤的发病率.
- 组之间并发症和治愈率是可比的,但超肥胖患者住院时间更长.
结论:
- 副甲状腺切除术对于超肥胖患者来说是安全的手术,当它在大量的中心进行时.
- 独特的病理和增加的住院患者入院是偏甲状腺切除术患者超肥胖的特征.
- 这些发现支持在这种高风险人群中用适当的管理策略进行副甲状腺切除术的可行性.
相关概念视频
01:21Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445